SYNERGY-OUTCOMES Study Tests Retatrutide for Liver Disease Prevention | Retatrutide News

The SYNERGY-OUTCOMES study investigates retatrutide and tirzepatide for preventing liver disease in high-risk adults with MASLD. This trial is crucial f...
Clinical Trials · October 10, 2026